Advertisements



Onconova Therapeutics shares tumble 12%

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 21st, 2017

Why Did Cara Therapeutics Shares Tumble 13.6% in April?

Investors sold off shares in the pain-drug developer following a stock offering, and ahead of first-quarter earnings......»»

Category: topSource: foxnewsMay 6th, 2017

The Latest Buzz in Biotech

Shares in Juno Therapeutics and Amicus Therapeutics tumble on disappointing news, and one important drug at Pfizer takes a big step forward......»»

Category: topSource: foxnewsDec 6th, 2016

Mid-Day Market Update: U.S. Stocks Turn Higher; Nivalis Therapeutics Shares Tumble After Failed Drug Trial

  Midway through trading Tuesday, the Dow traded up 0.15 percent to 19,126.46 while the NASDAQ climbed 0.62 percent to 5,401.98. The S&P also rose, gaining 0.32 percent to 2,208.67. Leading and Lagging Sectors On Tuesday, healthcare shares gai.....»»

Category: earningsSource: benzingaNov 29th, 2016

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $31 million of Shares

Related Stocks: ODT,.....»»

Category: blogSource: gurufocusDec 8th, 2017

Denali Therapeutics shares surge 20.8% in their trading debut

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchDec 8th, 2017

Denali Therapeutics Enters the Market With a Bang

Denali Therapeutics entered the markets with a bang on Friday. In its initial public offering, the company priced its almost 14 million shares within the expected range......»»

Category: blogSource: 247wallstDec 8th, 2017

Biotech Denali Therapeutics shares surge more than 20% in trading debut

Shares of biotech Denali Therapeutics Inc. soared more than 20% in their trading debut Friday, after the company priced its initial public offering at the midpoint of its $17 to.....»»

Category: topSource: marketwatchDec 8th, 2017

Why Marinus Pharmaceuticals Shares Spiked On Sage Therapeutics News

Marinus Pharmaceuticals Inc (NASDAQ: MRNS) closed up 39.6 percent Thursday and continued another 3.9 percent pre-market Friday — but not on its own merits. read more.....»»

Category: blogSource: benzingaDec 8th, 2017

Sage Therapeutics shares gain another 2% as SunTrust raises stock price target to $178 vs. $116

Sage Therapeutics Inc. shares rose another 2% Friday, adding to prior-session gains of more than 70%, as SunTr.....»»

Category: topSource: marketwatchDec 8th, 2017

Here"s Why Marinus Pharmaceuticals Rose as Much as 41.1% Thursday

What happened Shares of clinical stage biopharma Marinus Pharmaceuticals NASDAQ MRNS rose over 41 today after larger peer Sage Therapeutics NASDAQ SAGE reported positive top line results for one of its drug candidates SAGE 217 in a phase 2 trial in major.....»»

Category: futuresSource: nasdaqDec 7th, 2017

LendingClub Shares Tumble to a Record Low

They fell as much as 23%. Shares of.....»»

Category: europeSource: fortuneDec 7th, 2017

Could Sage Therapeutics’ Depression Drug Be the Next Big Thing?

Sage Therapeutics saw its shares make an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial......»»

Category: blogSource: 247wallstDec 7th, 2017

Mid-Day Market Update: Duluth Holdings Drops Following Q3 Results; SAGE Therapeutics Shares Surge

Midway through trading Thursday, the Dow traded up 0.19 percent to 24,186.25while the NASDAQ climbed 0.66 percent to 6,821.13. The S&P also rose, gaining 0.28 percent to 2,636.59. read more.....»»

Category: blogSource: benzingaDec 7th, 2017

Heron Therapeutics (HRTX) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsDec 7th, 2017

UPDATE: Sage Therapeutics shares soar more than 74% on positive trial of depression treatment

Sage Therapeutics Inc. shares soared more than 74% in premarket trade Thursday, after the c.....»»

Category: topSource: marketwatchDec 7th, 2017

Here"s Why Duluth Holdings Is Sinking Today

Shares tumble after the company's third-quarter results come up short of expectations......»»

Category: topSource: foxnewsDec 7th, 2017

30 Stocks Moving In Tuesday"s Mid-Day Session

Gainers Revance Therapeutics, Inc. (NASDAQ: RVNC) shares jumped 33.7 percent to $34.75 after the company disclosed that its RT002 met primary and all secondary endpoints. read more.....»»

Category: blogSource: benzingaDec 5th, 2017

Mid-Afternoon Market Update: Francesca"s Drops On Earnings Miss; Revance Therapeutics Shares Gain

Toward the end of trading Tuesday, the Dow traded down 0.09 percent to 24,268.65 while the NASDAQ climbed 0.39 percent to 6,801.80. The S&P also rose, gaining 0.05 percent to 2,640.71. read more.....»»

Category: blogSource: benzingaDec 5th, 2017

UPDATE: Revance stock surges and Allergan drops on positive results for wrinkle injection

Revance Therapeutics Inc. shares surged nearly 38% in extremely heavy morning trade Tuesday after the company reported positive results for.....»»

Category: topSource: marketwatchDec 5th, 2017

Revance Scores Solid Results in Late-Stage Trial

Shares of Revance Therapeutics saw a solid gain early on Tuesday after the company announced positive top-line results from its late-stage trials......»»

Category: blogSource: 247wallstDec 5th, 2017